SPL 1.05% 9.6¢ starpharma holdings limited

If Viraleze 7 day treatment is competing with Paxlovid - who wins

  1. 855 Posts.
    lightbulb Created with Sketch. 139
    https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
    https://hotcopper.com.au/data/attachments/6066/6066766-3ef5d108380d32146a4952f5c936e33d.jpg
    https://hotcopper.com.au/data/attachments/6066/6066769-dad60aa245edf0ed4ba89ac3153644b5.jpg

    Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
    Last edited by Starlink: 29/03/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.